We demonstrate that ATXN1 is overexpressed in cervical cancer cells; this overexpression could have been induced by factors such as EGF and that EGF-mediated ATXN1 induction depends on the activation of the EGFR–RAS–MAPK pathway. The gene discussed is EGF; the disease is cervical carcinoma.